Development of Explosive Acne Fulminans After SARS-CoV-2 Vaccine Administration: A Case Report
This is a case study of a 23-year-old, active-duty male with a history of acne vulgaris but no personal history of vaccination reactions who was administered the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine and subsequently developed nodulocystic acne. He denied excessive physical activity, current anabolic steroid use, and changes in medications during that time frame; however, he admitted to using anabolic steroids and testosterone in the year prior to vaccine administration. The patient had dozens of thick, firm hypertrophic pink scars on the chest and back with surrounding tan macules on his back. The patient was treated with oral isotretinoin and pulsed dye laser (PDL) with eventual post-inflammatory hyperpigmentation noted after treatment. Although acne fulminans (AF) developed one month after SARS-CoV-2 administration, this is a hypothesis-generating clinical observation and temporal proximity alone does not prove causation.
Authors
- James M Fritsche
Institutions
- Naval Hospital Jacksonville (US)
Publication Details
- Journal
- Cureus
- Published
- 2026-11-16
- DOI
- https://doi.org/10.7759/cureus.119790
- Primary Topic
- Dermatological and COVID-19 studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- U.S. Navy